Last month, the Kaiser Family Foundation (KFF) released a series of charts that explain and compare various legislative proposals to lower prescription drug costs. Such proposals are in the limelight because many Americans identify drug pricing as a significant problem and support government action to address it. According to one KFF poll, high drug costs have kept 30% of Americans from taking their medicine as prescribed.

On Tuesday, the Supreme Court declined to fast-track the latest challenge to the Affordable Care Act (ACA). This decision not to expedite review comes after a federal appeals court last month agreed with a federal judge in Texas that the ACA’s individual mandate is unconstitutional, but declined to say how much of the law should fall as a result. Instead, the appeals court sent the case back to the Texas court to reconsider that question—a process that could take months if not years.

A new brief from the Kaiser Family Foundation (KFF) examines how state decisions to forego the Affordable Care Act’s (ACA) Medicaid expansion have impacted Americans’ access to coverage.

This week, the Center for Medicare Advocacy, a national nonprofit, released a new issue brief on an often-misunderstood aspect of coverage for people with chronic illness who need longer term care.

Just before the New Year, the Medicare Rights Center responded to a proposal that would damage the Medicaid program by allowing Tennessee to convert its Medicaid funding into a block grant. Our comments note that doing so would cause harm to older adults and people with disabilities, as well as the Medicaid program as a whole.

Yesterday, Medicare Rights Center President Fred Riccardi testified at a hearing of the House Committee on Energy and Commerce, Subcommittee on Health titled “Legislation to Improve Americans’ Health Care Coverage and Outcomes.”

In the testimony, Medicare Rights urged Congress to pass the bipartisan, bicameral Beneficiary Enrollment Notification and Eligibility Simplification (BENES) Act (H.R. 2477) without delay.

One year ago, in a deeply flawed ruling, a Texas judge found the portion of the Affordable Care Act (ACA)

This week, the U.S. House of Representatives is expected to consider the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3). This landmark bill takes significant steps to rein in high and rising prescription drug prices and lower costs for people with Medicare, including authorizing Medicare to negotiate prices for certain drugs and capping beneficiary out-of-pocket drug spending at $2,000 per year.

This week, a bipartisan group of leaders from the U.S. House of Representatives Committees on Energy & Commerce and Ways & Means sent a letter to the Centers for Medicare & Medicaid Services (CMS) expressing concerns with the redesigned Medicare Plan Finder (MPF). The letter points to errors that advocates and Medicare counselors experienced when using the new tool to help beneficiaries compare and select Medicare Advantage and Part D prescription drug plans during Fall Open Enrollment. In the letter, the leaders urge CMS to ensure that people with Medicare who relied on MPF information to choose a plan this year are held harmless and have the opportunity to make changes to their coverage in 2020.

The Medicare Rights Center applauds the passage of the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) by the U.S. House of Representatives. This landmark bill would significantly improve health care and prescription drug affordability for people with Medicare.